MissionIRNewsBreaks – Net Element, Inc. (NASDAQ: NETE) Subsidiary Collaborating with HP Inc. to Provide Cutting-Edge Solutions for SMB Market

Global technology and value-added solutions group Net Element (NASDAQ: NETE) today announced the entry into a channel partner agreement between its Aptito subsidiary with HP Inc. for sales and support of its line of Android-based POS devices. Under the agreement, Aptito will provide its restaurant management software-as-a-service (“SaaS”) alongside HP’s POS solutions. The collaboration will offer small and mid-sized businesses (“SMBs”) cutting-edge technology and competitively priced value-added services backed by HP’s global sales, support and Android-based IPOS solutions that incorporate a full suite of tools to enhance selling and mobile transactions. “We are excited to work with HP to deliver our SaaS in their IPOS solutions to our existing and new merchants worldwide,” Aptito President Andrey Krotov commented in the news release. “Aptito is currently deployed in 16 countries and growing, HP’s global sales and support provide a springboard for continued expansion.”

To view the full press release, visit http://ibn.fm/HmYP1

About Net Element Inc.

Net Element (NASDAQ: NETE) operates a payments-as-a-service transactional and value-added services platform for small to medium enterprise (“SME”) in the United States and selected emerging markets. In the U.S., the company aims to grow transactional revenue by innovating SME productivity services using blockchain technology solutions and Aptito, the company’s cloud-based, restaurant and retail point-of-sale solution. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest-growing companies in North America on Deloitte’s 2017 and 2018 Technology Fast 500. In 2017, Net Element was recognized by South Florida Business Journal as one of 2016’s fastest-growing technology companies. Further information is available at www.NetElement.com.

NOTE TO INVESTORS: The latest news and updates relating to NETE are available in the company’s newsroom at http://ibn.fm/NETE 

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) Posts Q4 and 2018 Annual Financial, Operational Results

VIVO Cannabis (TSX.V: VIVO) (OTCQX: VVCIF), a leading provider of premium cannabis products and services for the medical and adult-use markets and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited, Abcann Medicinals Inc. and Harvest Medicine Inc., this morning announced the release of its Q4 and 2018 annual financial and operating results. “The VIVO team achieved significant milestones in 2018, leading to substantial increases in net revenue, cash position, production capacity, organizational effectiveness and customer development,” VIVO CEO Barry Fishman said in the news release. “The strategic acquisitions of Canna Farms and Harvest Medicine were important drivers of our improved financial results. Through the acquisition of Canna Farms, we have added an award-winning BC craft brand, are leveraging best practices, and have dramatically increased capacity. Harvest Medicine provides a scalable network of medical cannabis clinics offering industry-leading patient care and access to critical data to shape our innovative product development efforts. VIVO remains committed to changing the way people view cannabis and to ensuring medical patients and adult-use consumers have access to our premium cannabis products and services.”

To view the full press release, visit http://ibn.fm/iSdn6

About VIVO Cannabis(TM)

VIVO Cannabis(TM), based in Napanee, Ontario, is recognized for trusted, high-quality products and services. It holds production and sales licenses from Health Canada and operates world-class indoor cultivation facilities with proprietary plant-growing technology. VIVO has a collection of premium brands targeting unique customer segments, including Beacon Medical(TM), FIRESIDE(TM), Canna Farms(TM) and Lumina(TM). In August 2018, VIVO acquired Canna Farms, a premium cannabis company based in Hope, British Columbia. Canna Farms was B.C.’s first Licensed Producer and has several years of craft cultivation experience and expertise, as well as a significant patient base and positive cash flow. The Company is significantly expanding its production capacity and pursuing partnership and product development opportunities domestically, as well as in select international markets, including Germany and Australia. VIVO also operates Harvest Medicine, a patient-centric and highly scalable network of specialty medical cannabis clinics as well as a free telemedicine app. VIVO has a healthy balance sheet and is well-positioned to accelerate its growth in Canada and internationally. For more information, visit the company’s website at www.VivoCannabis.com.

NOTE TO INVESTORS: The latest news and updates relating to VVCIF are available in the company’s newsroom at http://ibn.fm/VVCIF

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – The Green Organic Dutchman Holdings Ltd.’s (TSX: TGOD) (OTCQX: TGODF) Extraction Services Provider Obtains Organic Certification

Cannabis-focused research and development company The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) this morning announced that its Kelowna-based extraction processing services provider, Valens GroWorks Corp., has obtained its organic certification from Pro-Cert Organic Systems Ltd. “TGOD has been committed to organic since day one. Working with service providers who embrace organic as much as we do is paramount.  I want to congratulate the team at Valens for obtaining their organic certification,” Brian Athaide, CEO of TGOD, stated in the news release. “We look forward to delivering certified organic oils of the highest standards to our patients and customers.” As per a previous announcement, TGOD will have exclusive access to Valens’ services for certified organic extraction processing for a period of one year.

To view the full press release, visit http://ibn.fm/LDalV

About The Green Organic Dutchman Holdings Ltd.

The Green Organic Dutchman Holdings is a publicly traded, premium global organic cannabis company with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. The company grows high-quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a planned global capacity of 219,000 kgs. and is building 1,643,600 square feet of cultivation and processing facilities across Ontario, Quebec, Jamaica and Denmark. For more information, visit the company’s website at www.TGOD.ca

NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://ibn.fm/TGODF

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Receives Sales License, Offers Access to Organic Cannabis Oils

• TGOD recently received an oil sales license from Health Canada for its Ancaster, Ontario, facility
• The company’s state-of-the-art supercritical CO2 extraction system is capable of processing ultra-pure, certified-organic cannabis oils
• TGOD’s Unite Organic Cannabis Oil, derived from a high potency, THC-dominant strain, is expected to be ready to ship in late April 2019
• The company is targeting a potential market in Ontario and Quebec with 21.5 million residents and an estimated value of more than $2.6 billion

Cannabis company The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) has reached another milestone that supports the company’s ambition of becoming the global leader in delivering premium organic cannabis solutions to enhance people’s lives. TGOD recently announced that it is now licensed to sell cannabis oils produced at its Ancaster, Ontario, facility, which previously received an oil production license in April 2018. The oil sales license and production license were both issued by Health Canada, pursuant to the Cannabis Act, according to a news release (http://ibn.fm/58yr1).

“We are pleased to offer TGOD’s medical patients access to new premium certified organic cannabis oils,” Brian Athaide, TGOD CEO, said in the release. “In addition, this step will assist TGOD in transforming our premium quality organic raw material into a variety of higher-margin cannabis products which is core to our business plan, providing us with the opportunity to bring to market innovative and novel products, including beverages and edibles, once regulations permit. Cannabis 2.0 is rapidly approaching, and we will be ready.”

TGOD’s oils will be as close to the original plant as possible, including terpene profiles to realize entourage effects. The process is easily customizable to create full-spectrum, strain-specific oils, as well as oils of varying cannabinoid and terpene concentrations. TGOD Chief Science Officer Dr. Rav Kumar noted in a release that the oil is predominantly a medical product and patients want clean, organic efficacy with safe and easy delivery.

TGOD produces farm grown, organic, pesticide-free medical cannabis using all-natural, organic craft growing principles. These products are laboratory tested to ensure that patients have access to a standardized, safe and consistent product. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis and has positioned itself as one of the highest quality and most cost-efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions (http://ibn.fm/ORqip).

“Through our certified organic product and process we know we are providing patients the best possible experience,” Kumar added. In March, the first group of patients enrolled in the TGOD’s Growers’ Circle received access to purchase the company’s first certified organic cannabis strain through its newly redesigned, award-winning website (http://ibn.fm/WcaTQ).

TGOD’s state-of-the-art supercritical CO2 extraction system is capable of processing ultra-pure, environmentally friendly, organic cannabis oils that are free of toxic solvents. The company’s oil extraction facility was built to current Good Manufacturing Practices (cGMP) specifications, and work is currently underway for European Union GMP (“EU-GMP”) certification, which would allow TGOD to expand distribution of its certified organic cannabis oils beyond Canada and into global markets.

Arcview Market Research, in partnership with BDS Analytics, projects that the edibles market could be worth more than $4.1 billion in Canada and the United States by 2022 (http://ibn.fm/RNW2f). Health Canada is finetuning regulations for sales of cannabis-infused edibles, drinks, extracts and topicals, which are expected to be allowed nationwide no later than October 17, 2019.

For more information, visit the company’s website at www.TGOD.ca

NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://ibn.fm/TGODF

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) Announces Application for Permanent Licenses for Adelanto, California Facility

TransCanna Holdings (CSE: TCAN) (FSE: TH8) today announced that it has applied for a permanent manufacturing, distribution and a transportation license with the city of Adelanto, California. In addition, the company intends to provide an update later in the week relating to the licensing process for its 196,000 square foot facility based in Modesto, California. “Our immediate focus is to be able to have our city and state licenses in place in Adelanto as soon as possible,” TransCanna CEO Jim Pakulis said in the news release. “Subsequent to the GoodFellas acquisition we will be able to prepare and package the Daily Cannabis Brand pre-rolls at the facility and then deliver the products to the dispensaries without the need to bring in a third party.”

To view the full press release, visit http://ibn.fm/yVFGk

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a Canadian-based company focused on providing integrated branding, transportation and distribution services, through its wholly-owned California subsidiaries, to a range of industries including the cannabis marketplace. For more information, visit the company’s website at www.TransCanna.com.

NOTE TO INVESTORS: The latest news and updates relating to TCAN are available in the company’s newsroom at http://ibn.fm/TCAN

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Innovative Technology Improves Delivery of Nicotine, Cannabinoids

Biotechnology company and drug-delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP)has developed and out-licenses its pioneering-drug delivery platform DehydraTECH(TM), which improves the speed, taste and delivery of bioactive compounds, including nicotine and cannabinoids. A recent article discussing the company reads, “Furthermore, the DehydraTECH drug delivery platform increases bio-absorption by up to 10 times and lessens the time of onset, with effects being felt within 15 to 20 minutes, as compared to 60 to 120 minutes without the platform. In addition, the technology is patent protected for cannabidiol (CBD) and all other nonpsychoactive cannabinoids. Patents are also granted for THC (tetrahydrocannabinol), other psychoactive compounds and NSAIDs (nonsteroidal, anti-inflammatory drugs), as well as nicotine and other molecules. . . . Lexaria Bioscience has partnered with one of the world’s largest tobacco companies to fund the research and development of the DehydraTECH technology for oral nicotine. Through wholly owned subsidiary Lexaria Nicotine LLC, Lexaria is working to propel innovation in oral, reduced-risk nicotine consumer products utilizing DehydraTECH (http://ibn.fm/1JjdR).”

To view the full article, visit http://ibn.fm/smpO8

About Lexaria Bioscience Corp.

Lexaria Bioscience has developed and out-licenses its disruptive delivery technology, which promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the United States and Australia for utilization of its DehydraTECH delivery technology. Lexaria’s technology provides increases in intestinal absorption rates, more rapid delivery to the bloodstream, and important taste-masking benefits for orally administered bioactive molecules including cannabinoids, vitamins, nonsteroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Cannabis Strategic Ventures Inc. (NUGS) Realizes Key Achievements

Los Angeles, California-based cannabis firm Cannabis Strategic Ventures (OTC: NUGS), through its diverse portfolio of subsidiaries, is focused on supporting entrepreneurial growth within the cannabis sector. An article discussing the company reads, “Thus far in 2019, NUGS has filed an application for uplisting to the OTCQB Venture Market; announced that it will partner with a Santa Barbara County cultivation operation that holds about 40 commercial cannabis licenses in Southern California; revealed that it will add a six-acre Northern California site to its holdings after having obtained over 20 licenses for cannabis manufacturing, distribution and cultivation there; and secured an investment of up to $3 million from student-led business Triton Funds subsequent to an upcoming S1 registration statement, which will allow Cannabis Strategic Ventures to accelerate its cultivation business priorities and the expansion of its existing portfolio brands.”

To view the full article, visit http://ibn.fm/Rq84e

About Cannabis Strategic Ventures Inc.

Cannabis Strategic Ventures is a Los Angeles-based firm that incubates, develops and partners with category leaders within the cannabis sector. The firm’s NUGS brand experience provides mentorship and a range of essential services to emerging and existing cannabis consumer brands. The company recently completed a name and symbol change from Cascade Energy Inc. Cannabis Strategic Ventures is publicly traded on the U.S. Over-the-Counter Market with the stock symbol NUGS. For more information, visit the company’s website at www.CannabisStrategic.com.

NOTE TO INVESTORS: The latest news and updates relating to NUGS are available in the company’s newsroom at http://ibn.fm/NUGS 

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Announces European Subsidiary’s Receipt of Organic Certification

Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) this morning announced receipt of organic certification by its wholly owned subsidiary, HemPoland, from EKOGWARANCJA PTRE, the largest certification body supported by the Polish Ministry of Agriculture and Rural Development. According to the update, HemPoland’s facilities, production processes and product offerings are now certified organic. “We are incredibly excited that HemPoland’s facilities, production and processes have received organic certification within Europe,” TGOD CEO Brian Athaide said in the news release. “This is a major point of differentiation that offers consumers a premium experience. We are proud to continue to deliver and execute on our global organic strategy.”

To view the full press release, visit http://ibn.fm/YJacm

About The Green Organic Dutchman Holdings Ltd.

The Green Organic Dutchman Holdings is a publicly traded, premium global organic cannabis company with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. The company grows high-quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a planned global capacity of 219,000 kgs. and is building 1,643,600 square feet of cultivation and processing facilities across Ontario, Quebec, Jamaica and Denmark. For more information, visit the company’s website at www.TGOD.ca.

NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://ibn.fm/TGODF

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) Announces Expiration of Former Offer for Aphria Inc. (TSX: APHA) (NYSE: APHA)

Lifestyle-oriented cannabis company Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) on Thursday announced the expiration of its formal offer to acquire all of the issued and outstanding common shares of Aphria Inc. (TSX: APHA) (NYSE: APHA). According to the update, the company will not be taking up any Aphria shares as the offer conditions have not been met. As announced on April 15, 2019, Green Growth Brands and Aphria entered into an agreement to shorten the offer acceptance expiry time from 5:00 PM (Toronto time) on May 9, 2019 to 5:00 PM (Toronto time) on April 25, 2019. The company has determined not to extend the offer expiry date, and all Aphria shares tendered to the offer will be promptly returned to Aphria shareholders.

To view the full press release, visit http://ibn.fm/nbe7V

About Green Growth Brands

Green Growth Brands creates remarkable experiences in cannabis and CBD, led by CEO Peter Horvath and a leadership team of consumer-focused retail experts. The company’s brands include CAMP, Seventh Sense Botanical Therapy, The+Source, Green Lily and Meri + Jayne, with a licensing agreement with the Greg Norman Brand. Already boasting the strongest sales per square feet in the cannabis industry, GGB is expanding its presence in Nevada, Massachusetts and Arizona with CBD presence at ShopSeventhSense.com, in malls across the country and at DSW shoe stores—and that’s just the beginning. For more information, visit the company’s website at www.GreenGrowthBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to GGBXF are available in the company’s newsroom at http://ibn.fm/GGBXF

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Youngevity International Inc. (NASDAQ: YGYI) Subsidiary Secures Notable CBD Supply Contract

Youngevity International (NASDAQ: YGYI), a leading omni-direct lifestyle company, recently announced that its Khrysos Global subsidiary secured a contract to produce 99% pure cannabidiol oil from hemp with no tetrahydrocannabinol (THC). An article discussing the company reads, “The one-year supply and processing agreement is expected to begin with shipments this month and continue in equal amounts through March 2020, amounting to what Khrysos President Dwayne Dundore described as 50 percent of the company’s production capacity utilizing its supercritical CO2 technology (http://ibn.fm/FH1l7). Contracts for the remainder of the company’s production capacity are expected to be executed during ‘the next few months,’ he added. . . . ‘We are excited to reach the revenue stage for the end-to-end processing component of our business model,’ Dundore stated in the news release. ‘Due to customer demand, we are implementing our plan of increasing our end-to-end processing capabilities by 10 times in Q3 of this year, providing estimated annual revenue potential in excess of $220 million at current market prices.’”

To view the full article, visit http://ibn.fm/oDUZd

About Youngevity International Inc.

Youngevity International Inc. is a multichannel lifestyle company operating in three distinct business segments — a commercial coffee enterprise, a commercial hemp enterprise and an omni-direct selling platform. The company features an international selling network and has assembled a virtual main street of products and services under one corporate entity. YGYI offers products from the six top-selling retail categories, including health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry and innovative services. For more information, visit the company’s website at www.YGYI.com.

NOTE TO INVESTORS: The latest news and updates relating to YGYI are available in the company’s newsroom at http://ibn.fm/YGYI

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – VIVO Cannabis Inc.’s (TSX.V: VIVO) (OTCQX: VVCIF) Canna Farms Receives Local Municipal Approval for B.C. Facility Expansion

VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) this morning announced receipt of local municipal approval for its wholly-owned subsidiary, Canna Farms Limited, for its phase 5 expansion that will add to its Hope, B.C. facility an incremental 2,500 kilograms of indoor capacity. According to the update, the expansion, originally slated to begin construction in 2020, is now, pending regulatory approval, expected to be completed in late 2019 or early 2020. The expansion, with expected capital costs of $3.5 million, consists of 10,000 square feet of cultivation space and is expected to bring VIVO’s total internal production capacity to 13,500 kilograms by early 2020. “Canna Farms is a cultivator and purveyor of premium quality, award winning, small-batch craft cannabis with widespread recognition and appeal as evidenced by its award for ‘Top Reviewed Licensed Producer of the Year’ at the 2018 Canadian Cannabis Awards,” VIVO CEO Barry Fishman said in the news release. “This expansion will further increase Canna Farms’ production capacity to help meet the significant market demand for premium B.C. dry bud. This project represents a strategic deployment of a minor portion of our strong cash position as the Company continues to invest to drive future growth.”

To view the full press release, visit http://ibn.fm/QZkEM

About VIVO Cannabis(TM)

VIVO Cannabis(TM), based in Napanee, Ontario, is recognized for trusted, high-quality products and services. It holds production and sales licenses from Health Canada and operates world-class indoor cultivation facilities with proprietary plant-growing technology. VIVO has a collection of premium brands targeting unique customer segments, including Beacon Medical(TM), FIRESIDE(TM), Canna Farms(TM) and Lumina(TM). In August 2018, VIVO acquired Canna Farms, a premium cannabis company based in Hope, British Columbia. Canna Farms was B.C.’s first Licensed Producer and has several years of craft cultivation experience and expertise, as well as a significant patient base and positive cash flow. The Company is significantly expanding its production capacity and pursuing partnership and product development opportunities domestically, as well as in select international markets, including Germany and Australia. VIVO also operates Harvest Medicine, a patient-centric and highly scalable network of specialty medical cannabis clinics as well as a free telemedicine app. VIVO has a healthy balance sheet and is well-positioned to accelerate its growth in Canada and internationally. For more information, visit the company’s website at www.VivoCannabis.com.

NOTE TO INVESTORS: The latest news and updates relating to VVCIF are available in the company’s newsroom at http://ibn.fm/VVCIF

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Expands Advisory Board; Subsidiary Enters Beverage License Agreement

Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) on Wednesday announced that, through its subsidiary Lexaria CanPharm ULC, it has entered a definitive 5-year agreement to provide Lexaria’s patented DehydraTECH(TM) technology to a private California-based cannabis company. Under the agreement the cannabis company will utilize the technology in certain cannabis-based beverages to be produced and sold in the states of California and Nevada. DehydraTECH-enabled beverages are protected under Lexaria’s many existing US-granted patents and may include any combination of ready-to-drink beverages such as non-alcoholic beers, wines and spirits; cold or hot coffee or teas, sports drinks and much more. In addition, Lexaria this morning announced the addition of Dr. Dwayne Godwin, Dr. Terry D. Blumenthal, Dr. Matthew Fraser and Dr. Carla Lema Tome to its Scientific Advisory Board. Each of the new appointees will contribute support, advice and recommendations related to the company’s scientific research and product development. “Lexaria Bioscience Corp. is very pleased to welcome these accomplished experts to our Advisory Board, who can provide critical scientific guidance to Lexaria’s ongoing and future R&D programs,” Lexaria CEO Chris Bunka said in the news release. “Lexaria is building towards becoming one of the world’s leaders in drug delivery technology and our most recent Advisors can assist in achieving that goal.”

To view the full press releases, visit http://ibn.fm/vWtDM and http://ibn.fm/Hc2du

About Lexaria Bioscience Corp.

Lexaria Bioscience has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the United States and Australia for utilization of its DehydraTECH delivery technology. Lexaria’s technology provides increases in intestinal absorption rates, more rapid delivery to the bloodstream, and important taste-masking benefits for orally administered bioactive molecules including cannabinoids, vitamins, nonsteroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Cannabis Strategic Ventures Inc. (NUGS) Plants Over 20,000 Marijuana Clones to Launch NUGS Farm North

Cannabis Strategic Ventures (OTC: NUGS), a Los Angeles, California-based cannabis firm, this morning announced the launch of a six-acre cannabis cultivation site which is anticipated to produce more than 30,000 pounds of cannabis per harvest, with an expectation of four to five harvests per year. Based on its location in Northern California, the site has been named NUGS Farm North and boasts 24 cultivation, manufacturing and distribution licenses issued by the Bureau of Cannabis Control in the State of California. According to the update, the company has planted over 20,000 marijuana clones this week and plans to plant 10,000 more in the coming week. The site is expected to operate at maximum capacity by late summer of this year. “NUGS Farm North is in a prime location. We have assembled a great team to operate the site and to market and distribute its outputs. We have already begun cultivation and believe the marketplace is primed for the type of premium cannabis flower we are cultivating. We look forward to a successful operation at our flagship cultivation site,” Cannabis Strategic Ventures CEO Simon Yu stated in the news release.

To view the full press release, visit http://ibn.fm/hKb2D

About Cannabis Strategic Ventures Inc.

Cannabis Strategic Ventures is a Los Angeles-based firm that incubates, develops and partners with category leaders within the cannabis sector. The firm’s NUGS brand experience provides mentorship and a range of essential services to emerging and existing cannabis consumer brands. The company recently completed a name and symbol change from Cascade Energy Inc. Cannabis Strategic Ventures is publicly traded on the U.S. Over-the-Counter Market with the stock symbol NUGS. For more information, visit the company’s website at www.CannabisStrategic.com.

NOTE TO INVESTORS: The latest news and updates relating to NUGS are available in the company’s newsroom at http://ibn.fm/NUGS 

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Net Element Inc.’s (NASDAQ: NETE) North American Transaction Solutions Segment Drives Noteworthy Revenue Growth

Net Element (NASDAQ: NETE), a global technology and value-added solutions group, recently reported substantial financial growth in 2018. A recent article discussing the company reads, “The company’s revenue over the year went up to $65.8 million, marking an increase of 10 percent on an annual basis. Growth through the company’s North American transaction solutions segment was the primary driver for the strong results, as the company’s management announced in an earnings conference call on April 2, 2019 (http://ibn.fm/ZfEls).  . . . The North American transaction solutions segment experienced annual growth of 16 percent in 2018. The United States accounted for 90 percent of the overall revenue, while international revenue contributed 10 percent.”

To view the full article, visit http://ibn.fm/jh86B

About Net Element Inc.

Net Element (NASDAQ: NETE) operates a payments-as-a-service transactional and value-added services platform for small to medium enterprise (“SME”) in the United States and selected emerging markets. In the U.S., the company aims to grow transactional revenue by innovating SME productivity services using blockchain technology solutions and Aptito, the company’s cloud-based, restaurant and retail point-of-sale solution. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest-growing companies in North America on Deloitte’s 2017 Technology Fast 500. In 2017, Net Element was recognized by South Florida Business Journal as one of 2016’s fastest-growing technology companies. Further information is available at www.NetElement.com.

NOTE TO INVESTORS: The latest news and updates relating to NETE are available in the company’s newsroom at http://ibn.fm/NETE 

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) to Host Teleconference to Discuss Q4 and FY2018 Financial Results and Provide Business Update

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of high pressure-based instruments, consumables, and related services for the global life sciences and other industries worldwide, today announced its plans to host a teleconference to discuss its Q4 and fiscal year 2018 financial results and to provide a business update. The teleconference, scheduled to be held on Thursday, April 25, 2019 at 4:30 PM ET, will include a company presentation followed by a question and answer period. Interested parties may listen to the teleconference live by dialing (844) 602-0380 (North America) or (862) 298-0970 (International), and stating the following verbal passcode to the operator: PBI Fourth Quarter and FY 2018 Financial Call & Business Update. A replay will be available beginning Friday, April 26, 2019, which will be accessible via telephone and the company’s website for 30 days. To listen to the replay via telephone, interested parties may dial (877) 481-4010 (North America) or (919) 882-2331 (International), and enter replay passcode: 47337.

To view the full press release, visit http://ibn.fm/8wUkF

About Pressure BioSciences Inc.

Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). PBIO’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of its pressure-based technologies in the following areas: (1) the use of its recently acquired PreEMT technology from BaroFold, Inc. to allow entry into the biologics contract research services sector, and (2) the use of its recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) Completes Acquisition of Large California Site with Closed-Loop Cannabis Production Potential

• TransCanna Holdings’ purchase of a 5.5-acre site in Northern California with a 196,000-square-foot facility onsite is expected to set the stage for the company’s self-contained ecosystem to create or acquire 15 premium brands by controlling all aspects of production, distribution and sales
• Cannabis sales in California are expected to reach $5.1 billion this year and climb to $7.7 billion by 2022
• TransCanna’s site purchase advances plans for an additional 600,000-square-foot facility for biomass growth
• A successful, oversubscribed private placement raised gross proceeds of C$16 million to help fund plans for the site

Cannabis branding and distribution company TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) has finalized the acquisition of “arguably the largest vertically integrated cannabis centric” multi‐purpose facility in California, setting the stage for edification of a self-contained cannabis hub operation that includes integrated divisions for transportation and distribution, cultivation and nursery, lab extraction, manufacturing and packaging.

The three-story, 196,000-square-foot facility is part of a larger 5.5-acre property purchase that the company envisions as green space, where up to 600,000 square feet of new structure can be built to grow TransCanna’s own biomass for its brands.

“Simultaneous to putting our efforts into purchasing the facility, we’ve been searching extensively for the key individuals who will be overseeing the day to day operations. We’ve made great strides over the past several weeks and should be able to start making announcements by the end of the month,” TransCanna CEO Jim Pakulis stated in a news release (http://ibn.fm/xHbpX).

The total purchase price was $15 million. The seller of the building agreed to a carry-back note of $6.75 million at seven percent interest for up to 13 months, with an initial maturity date of October 15 and the possibility of a six-month extension under a share and share warrant issuance agreement.

A brokered private placement for five million units of shares and warrants to help fund the purchase was increased to eight million units for gross proceeds of C$16 million after the investment vehicle was oversubscribed in March (http://ibn.fm/GcpSK).

The seller completed $8 million in renovation improvements prior to the purchase to bring parts of the site’s potential up to U.S. Department of Agriculture standards for safety and sanitation in processing biomass, with cannabis packaging and processing equipment included. Making the existing facility operational would require an additional investment of approximately $1.5 million. The structure has not yet been licensed for cannabis production, but TransCanna expects to use it for the varied aspects of its cannabis production and distribution operations as those permissions are granted.

“We believe the consistency in our ecosystem that we can offer, and the scale that we can create, will result in TransCanna owning a portfolio of premium brands that will materially benefit the retailer and their customers,” Pakulis added (http://ibn.fm/eEASP).

Analysts at Arcview Market Research, partnering with BDS Analytics, forecast a legal cannabis market in the United States that will experience double-digit growth from 2018 to 2022, passing $23 billion in sales by 2022 with a 22 percent CAGR (http://ibn.fm/L7j2G). A Cannabis Business Plan report predicts that California’s cannabis market will reach $7.7 billion in annual revenues by 2022 (http://ibn.fm/30cwH), while BDS Analytics expects sales of cannabis to hit $5.1 billion this year in California alone (http://ibn.fm/Kby5q).

For more information, visit the company’s website at www.TransCanna.com

NOTE TO INVESTORS: The latest news and updates relating to TCAN are available in the company’s newsroom at http://ibn.fm/TCAN

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

ChineseInvestors.com Inc.’s (CIIX) CBD Biotech Introduces Hemp-Plant Extraction and Cosmetics at Expo in Hanoi

• CIIX’s CBD Biotechnology Co. Ltd. explored new partnership opportunities at Vietnam Expo
• CBD Biotech exhibited self-branded, hemp-infused skin care line
• CIIX aims to build new markets for industrial hemp products throughout Asia

ChineseInvestors.com Inc.’s (OTCQB: CIIX) wholly owned foreign enterprise, CBD Biotechnology Co. Ltd., introduced its new efforts in hemp plant extraction and associated cosmetics at the 29th Vietnam Expo in Hanoi, which was held on April 10-13. The company exhibited its self-branded, hemp-infused skin care line, establishing CBD Biotech as one of the first companies in China to offer skin care products infused with hemp oil and hemp leaf extract (http://ibn.fm/wpIGP).

Participating in the event enabled CBD Biotech to explore industrial hemp sales throughout Asia, raise its profile among potential partners and become an influencer in the market. CBD Biotech has been a pioneer in the Chinese market for hemp-infused skin care products and an originator of hemp plant extraction. The company also exhibited its hemp wine at the expo (http://ibn.fm/UvDtK).

“The Vietnam Expo continues to be an important business destination to build bridges for trade promotion, foreign relations, facilitating commerce and attracting trade between Vietnamese and foreign enterprises,” CBD Biotech CEO Summer Yun stated in a news release (http://ibn.fm/5EG6R). “We anticipate creating lucrative export opportunities and exploring possible expansion to more Southeast Asian countries and members of ASEAN.”

CBD Biotech’s current line of skin care products features the Popular Series, Live Oxygen Series, Plant Series and New Products Series.

The Vietnam Expo showcased 760 companies in more than 1,000 booths. Some 35 percent of the booths represent international companies, while 65 percent are companies based in Vietnam.

For more information, visit the company’s website at www.ChineseInvestors.com

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – TransCanna Holdings Inc.’s (CSE: TCAN) (FSE: TH8) GoodFellas Acquisition to Include Daily Cannabis Goods Brand

TransCanna Holdings (CSE: TCAN) (FSE: TH8) today announced that its acquisition of GoodFellas will result in acquiring an additional existing brand, Daily Cannabis Goods. Per the update, the Daily brand consists of three quality, attractively packaged and priced half gram pre-rolls. TransCanna anticipates expanding the Daily line to include three additional SKUs subsequent to the acquisition. “The Daily brand is a perfect fit for TransCanna,” TCAN CEO Jim Pakulis stated in the news release. “The start-up costs were nominal, it has SKU velocity now that it’s selling in over thirty dispensaries, and it’s constantly beating the competition due to consumer demand.”

To view the full press release, visit http://ibn.fm/cVmdT

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a Canadian-based company focused on providing integrated branding, transportation and distribution services, through its wholly-owned California subsidiaries, to a range of industries including the cannabis marketplace. For more information, visit the company’s website at www.TransCanna.com.

NOTE TO INVESTORS: The latest news and updates relating to TCAN are available in the company’s newsroom at http://ibn.fm/TCAN

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Why Genprex Inc. (NASDAQ: GNPX) Is ‘One to Watch’

Clinical-stage, gene-therapy company Genprex (NASDAQ: GNPX) is focused on the development of potentially life-changing technologies for cancer patients. A recent article discussing GNPX reads, “Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer. . . . Genprex’s initial product candidate is Oncoprex, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.”

To view the full article, visit http://ibn.fm/X2ovm

About Genprex Inc.

Genprex Inc. is a clinical-stage, gene-therapy company developing potentially life-changing technologies for cancer patients, based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex(TM) immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale, hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities. Oncoprex has a multimodal mechanism of action whereby it interrupts cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis, or programmed cell death, in cancer cells and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance. For more information, visit the company’s website at www.Genprex.com.

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://ibn.fm/GNPX

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Receives Cannabis Oil Sales License for Hamilton Facility

Cannabis company The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) this morning announced that it has received its oil sales license from Health Canada, pursuant to the Cannabis Act, for its facility in Hamilton, Ontario. This update follows the company’s April 2018 reception of its oils production license for the same facility. “We are pleased to offer TGOD’s medical patients access to new premium certified organic cannabis oils,” Brian Athaide, CEO of TGOD, stated in the news release. “In addition, this step will assist TGOD in transforming our premium quality organic raw material into a variety of higher-margin cannabis products which is core to our business plan, providing us with the opportunity to bring to market innovative and novel products, including beverages and edibles, once regulations permit.”

To view the full press release, visit http://ibn.fm/3a1qE

About The Green Organic Dutchman Holdings Ltd.

The Green Organic Dutchman Holdings is a publicly traded, premium global organic cannabis company with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. The company grows high-quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a planned global capacity of 219,000 kgs. and is building 1,643,600 square feet of cultivation and processing facilities across Ontario, Quebec, Jamaica and Denmark. For more information, visit the company’s website at www.TGOD.ca

NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://ibn.fm/TGODF

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html